ClinicalTrials.gg
Sign In

Lupus Nephritis clinical trials

The registry lists 340 studies for Lupus Nephritis across more than 10 countries. 135 are recruiting or about to start. 305 of them are mainly about Lupus Nephritis (how this is decided). Per ClinicalTrials.gov, last updated 2026-11-10.

Get an email when these change. Save the Lupus Nephritis studies recruiting or about to start — once a week, free: studies that open, close, add sites or post results.

Watch these studies
See an example email

Example · made-up studies

Breast cancer · Recruiting: 2 came in, 3 changed

What changed in your saved searches, Oct 31 – Nov 6:

A study of drug A after surgery for early breast cancer

Came in · now Recruiting

Drug B with hormone therapy in advanced breast cancer

Changed

· Sites: 4 added, including Seoul and Busan

· Enrollment: 300 → 450 participants

Exercise during chemotherapy

Now Active, not recruiting

One email a week for all your saved searches. Stop any time.

Status

Completed
98
Recruiting
88
Not yet recruiting
42
Status unknown
38
Terminated
34
Withdrawn
20

Phase

Phase 2
101
Phase 1
71
Phase 3
52
Phase 4
29
Early Phase 1
10

Where

United States
113
China
95
Spain
40
France
33
Germany
32
Mexico
32

Who runs them

Assiut University (22) · Novartis Pharmaceuticals (10) · Aurinia Pharmaceuticals Inc. (8) · Nanjing University School of Medicine (8) · Hoffmann-La Roche (7) · RenJi Hospital (6) · Sohag University (6) · Sun Yat-sen University (5)

What is being tested here

Drugs under test in Lupus Nephritis studies, those with the most open studies first. Medicines only given beside them are not counted. How drugs are counted

DrugOpenPhase 3All
Mycophenolic Acid7723
Cyclophosphamide5010
Voclosporin349
Dapagliflozin306
Obinutuzumab325
YTS109304
Fludarabine303
Rituximab247
Belimumab235
Belacabnagene franleucel202

Drug classes tested here Alkylating agents 5 open · Antimetabolites 3 open · Corticosteroids 2 open · Calcineurin inhibitors 1 open · Proteasome inhibitors 4

Coming up

11phase 3 studies under way
40studies finish main data collection within a year3 of them phase 3

Studies recruiting or running, from their records. “Main data collection” ends at the primary completion date, the sponsor’s own estimate, which often moves.

The 10 nearest, phase 3 first

Who these studies take

Of the 88 Lupus Nephritis studies recruiting now, 30 (34%) set no upper age limit and 51 (58%) stop at 75 or younger. 29 (33%) take children under 18. 1 (1%) are for women only and 0 (0%) for men only; 7 (8%) take healthy volunteers.

Recruiting studies that take each age, of 88
AgeWomenMen
1015 (17%)15 (17%)
1886 (98%)85 (97%)
3081 (92%)80 (91%)
4080 (91%)79 (90%)
5080 (91%)79 (90%)
6577 (88%)76 (86%)
7545 (51%)44 (50%)
8534 (39%)33 (38%)

Across all 340 studies, recruiting or not: 57% stop at 75 or younger and 30% at 65; 25% take children; 2% are for women only and 0% for men only; 9% take healthy volunteers. From each study’s registry entry; the criteria on its page decide.

How long Lupus Nephritis studies take

Of 33 phase 2 interventional studies under Lupus Nephritis, half reached primary completion within 40 months of starting, counting those still running.

Start to primary completionEvery sponsorIndustryNon-industry
Phase 240 mo28–57 · 33 studies——

Each figure is the month by which half the studies had reached primary completion, with the range in which the middle half did. Studies still running count until their last registry update; studies that stopped early are left out. Phase 1 includes early phase 1; observational means prospective or not stated, as retrospective and cross-sectional studies date a window of data rather than a study. How these figures are worked out

What changed recently

From the registry's own updates since Oct 13, 2026.

Started recruiting1

Stopped2

Newly registered4

Studies

Recruiting first, then most recently updated. Showing 50 of 340. Browse all 340 → or search them.